Latest News and Press Releases
Want to stay updated on the latest news?
-
ワシントン, March 21, 2017 (GLOBE NEWSWIRE) -- 発 ワシントンDCで開催された第66回年次米国心臓病学会学術集会 (American College of Cardiology (ACC)) において、最新の臨床研究特集として、アビオメッド (Abiomed、NASDAQ:ABMD) のインペラ品質 (Impella® Quality、IQ)...
-
- Real-World Data Representing 15,259 Patients WASHINGTON, March 19, 2017 (GLOBE NEWSWIRE) -- Data from Abiomed’s (NASDAQ:ABMD) Impella® Quality (IQ) Assurance Program, which includes the IQ...
-
DANVERS, Mass., March 16, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announces that there are more than 10...
-
マサチューセッツ州ダンバース, March 13, 2017 (GLOBE NEWSWIRE) -- Circulation Research誌に発表された新しい研究では、ハイリスク経皮的冠動脈インターベンション (HRPCI) 中にアビオメッド (Abiomed, Inc.) のインペラ2.5 (Impella 2.5®)...
-
DANVERS, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- A new study published in Circulation Research finds use of hemodynamic support with Impella® 2.5 heart pump during high-risk percutaneous coronary...
-
マサチューセッツ州ダンバース発（, Feb. 25, 2017 (GLOBE NEWSWIRE) -- 画期的な心臓サポートテクノロジーのリーディング･プロバイダー、アビオメッド （Abiomed,...
-
DANVERS, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, announced that it has supported more than 50,000...
-
DANVERS, Mass., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, is proud to support February’s American Heart Month....
-
日マサチューセッツ州ダンバースおよびサンフランシスコ発 , Jan. 27, 2017 (GLOBE NEWSWIRE) -- 画期的な心臓サポートテクノロジーのリーディング･プロバイダー、アビオメッド (Abiomed, Inc.、NASDAQ:ABMD)...
-
DANVERS, Mass., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2017 revenue of...